Human gene
MYO7A myosin VIIA
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2148 | Deafness, bilateral, and vestibular dysfunction, MYO7A-related | dog | MYO7A | one to one | Target evidence |
61.2
|
| 2148 | Deafness, bilateral, and vestibular dysfunction, MYO7A-related | pig | MYO7A | one to one | Target evidence |
61.2
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| Usher syndrome type 1B | MONDO:0700087 | 0.84 | 933 |
| autosomal recessive nonsyndromic hearing loss 2 | MONDO:0010807 | 0.79 | 954 |
| autosomal dominant nonsyndromic hearing loss 11 | MONDO:0011032 | 0.77 | 607 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.